Anthrax Edema Factor Peptide

Details for Product No. ABIN1004241
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Protein Name
Pubmed 4 references available
Catalog no. ABIN1004241
Quantity 50 µg
Price
281.69 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Available

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 16 amino acids near the carboxy terminus of Anthrax edema factor.
Alternative Name Anthrax EF
Research Area Bacteria, Gram positive bacteria
Application Notes Anthrax peptide is used for blocking the activity of Anti-Anthrax edema factor antibody . It usually blocks the antibody activity completely in ELISA by incubating the peptide with equal volume of antibody for 30 min at 37ºC.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer Supplied in PBS pH 7.2 (10 mM NaH₂PO₄, 10 mM Na₂HPO₄, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Preservative Sodium azide
Handling Advice For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. The peptide solution should be gently mixed before use.
Storage -20 °C
Storage Comment Store at -20°C, stable for one year.
Expiry Date 12 months
Product cited in: Lanahan, Williams, Sanders et al.: "Growth factor-induced delayed early response genes." in: Molecular and cellular biology, Vol. 12, Issue 9, pp. 3919-29, 1992 (PubMed).

Sweet, Leung, Kang et al.: "A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 166, Issue 11, pp. 6633-9, 2001 (PubMed).

Janeway, Medzhitov: "Innate immune recognition." in: Annual review of immunology, Vol. 20, pp. 197-216, 2002 (PubMed).

Takeda, Kaisho, Akira: "Toll-like receptors." in: Annual review of immunology, Vol. 21, pp. 335-76, 2003 (PubMed).

Reactivities (1)
back to top